Manufacturer
Eli Lilly and Company NDC Codes
Finished products listed with the FDA under labeler names that contain “Eli Lilly”.
Most-listed names
By number of FDA listings (strengths, forms and packages), not by sales.
Products
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Alimtapemetrexed disodium | Pemetrexed disodium heptahydrate 500 mg/20mL | Injection, Powder, Lyophilized, For solutionIntravenous | Eli Lilly and Company | 0002-7623 |
| Alimtapemetrexed disodium | Pemetrexed disodium heptahydrate 100 mg/4mL | Injection, Powder, Lyophilized, For solutionIntravenous | Eli Lilly and Company | 0002-7640 |
| Amyvidflorbetapir f 18 | Florbetapir f-18 51 mCi/mL | Injection, SolutionIntravenous | Eli Lilly and Company | 0002-1200 |
| Baricitinib | Baricitinib 4 mg/1 | Tablet, Film coatedOral | Eli Lilly and Company | 0002-6885 |
| BASAGLAR KwikPeninsulin glargine | Insulin glargine 100 [iU]/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-7715 |
| Cialistadalafil | Tadalafil 5 mg/1 | Tablet, Film coatedOral | Eli Lilly and Company | 0002-4462 |
| Cialistadalafil | Tadalafil 10 mg/1 | Tablet, Film coatedOral | Eli Lilly and Company | 0002-4463 |
| Cialistadalafil | Tadalafil 20 mg/1 | Tablet, Film coatedOral | Eli Lilly and Company | 0002-4464 |
| Cyramzaramucirumab | Ramucirumab 10 mg/mL | SolutionIntravenous | Eli Lilly and Company | 0002-7669 |
| Cyramzaramucirumab | Ramucirumab 10 mg/mL | SolutionIntravenous | Eli Lilly and Company | 0002-7678 |
| Ebglysslebrikizumab-lbkz | Lebrikizumab 250 mg/2mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-7772 |
| Ebglysslebrikizumab-lbkz | Lebrikizumab 250 mg/2mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-7797 |
| Emgalitygalcanezumab-gnlm | Galcanezumab 120 mg/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-1436 |
| Emgalitygalcanezumab-gnlm | Galcanezumab 120 mg/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-2377 |
| Evistaraloxifene hydrochloride | Raloxifene hydrochloride 60 mg/1 | TabletOral | Eli Lilly and Company | 0002-4184 |
| Forteoteriparatide | Teriparatide 250 ug/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-8400 |
| Forteoteriparatide | Teriparatide 250 ug/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-9678 |
| Foundayoorforglipron | Orforglipron calcium .8 mg/1 | Tablet, Film coatedOral | Eli Lilly and Company | 0002-4178 |
| Foundayoorforglipron | Orforglipron calcium 2.5 mg/1 | Tablet, Film coatedOral | Eli Lilly and Company | 0002-4503 |
| Foundayoorforglipron | Orforglipron calcium 5.5 mg/1 | Tablet, Film coatedOral | Eli Lilly and Company | 0002-4794 |
| Foundayoorforglipron | Orforglipron calcium 9 mg/1 | Tablet, Film coatedOral | Eli Lilly and Company | 0002-4803 |
| Foundayoorforglipron | Orforglipron calcium 14.5 mg/1 | Tablet, Film coatedOral | Eli Lilly and Company | 0002-4839 |
| Foundayoorforglipron | Orforglipron calcium 17.2 mg/1 | Tablet, Film coatedOral | Eli Lilly and Company | 0002-4953 |
| Humaloginsulin lispro | Insulin lispro 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | Eli Lilly and Company | 0002-7510 |
| Humaloginsulin lispro | Insulin lispro 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | Eli Lilly and Company | 0002-7516 |